THERAVANCE INC - CORPORATE OBLIG

CUSIP: 88338TAB0

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Debt / CORPORATE OBLIG
Market price (% of par)
93.9%
Total 13F principal
$243,585,000
Principal change
-$6,375,000
Total reported market value
$231,464,000
Number of holders
25
Value change
-$4,323,541
Number of buys
10
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 88338TAB0?
CUSIP 88338TAB0 identifies 88338TAB0 - THERAVANCE INC - CORPORATE OBLIG in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAVANCE INC - CORPORATE OBLIG as of Q2 2015

As of 30 Jun 2015, THERAVANCE INC - CORPORATE OBLIG was held by 25 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $243,585,000 in principal (par value) of the bond. The largest 10 bondholders included BAUPOST GROUP LLC/MA, HIGHBRIDGE CAPITAL MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, ADVENT CAPITAL MANAGEMENT /DE/, Castle Creek Arbitrage, LLC, Kamunting Street Capital Management, L.P., PIONEER INVESTMENT MANAGEMENT INC, LAZARD ASSET MANAGEMENT LLC, Ameriprise Financial Inc, and DEUTSCHE BANK AG\. This page lists 25 institutional bondholders reporting positions for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.